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The two coupling agents SPDP (N-succinimidyl-3-(2-pyridyldithio)propionate) and SATA (N-succinimidyi-S- 
acetylthioacetate) were compared in their efficiency and feasibility to couple monocional antibodies (Abs) via thioether 
linkage to liposomes functionalized by various lipophilic maleimide compounds like N-(3-maleimidopropionyl)-N2-pal - 
mitoyi-L-lysine methyl ester (MP-PL), N-(3-maleimidopropionyl)phosphatidylethanolamide (MP-PE), N6-(6-malei- 
midocaproyl)-N2-palmitoyI-L-iysine methyl ester (EMC-PL), and N-(6-maleimidocaproyl)phosphatidylethanolamine 
(EMC-PE). The composition of the iiposomes was soy phosphatidylcholine (SPC), cholesterol, maleimide compounds 
and a-tocopherol (1:0.2:0.02:0.01, mol parts), plus N4-oleyicytosine arabinoside (NOAC) as cytostatic prodrug (0.2 
mol parts) and a new, lipophilic and highly fluorescent dye N,N' -b is(1-hexylhepty l ) -3 ,4:9,10-pery lenebis(d icarboxi -  
mide) (BHPD, 0.006 mol parts). From the maleimide derivatives MP-PL was the most effective in terms of preservation 
of the coupling activity in dependence of iiposome storage. The coupling of the monoclonal A B8-24.3 (mouse IgG2b, 
MHC class I, anti H-gk b) and 11316-6 (rat IgG2a, anti B16 mouse melanoma) to the drug carrying liposomes was more 
effective and easier to accomplish with SATA as compared to SPDP. Coupling rates of 60-65% were obtained with 
SATA at molar ratios of 12 SATA: I  Ab:40 maleimide spacer groups on the surface of one liposome. The highest 
coupling rates with SPDP were obtained at the ratio of 24 SPDP:  1 Ab:40 liposomal maleimide groups, with an Ab 
binding efficiency of only 20-25%. The optimal in vitro binding conditions to specific target cells (EIA for 
BS-24.3-1iposomes and B16-F10 for IB16-6-1iposomes) were determined by cytofluorometric measurement of the 
iiposomal BHPD fluorescence with SATA linked Abs. Optimal immunoliposome binding to specific epitopes on the 
target cells was achieved with 1-2 Ab molecules coupled to one liposome, with immunoliposome concentrations of
20-130 nM and with a small incubation volume of 0.3-0.4 ml. The specificity of the binding of BS-24.3-1iposomes to 
EIA target cells was visualized by scanning electron microscopy. Antibody mediated endocytic uptake of immunolipo- 
somes could be demonstrated by transmission electron microscopy. 
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Introduction 
The targeted ehvery of drug-carrying hposomes to 
specific sites m the orgamsm requxres the attachment of
molecules hke Abs or their fragments to the surface of 
the hposomes Such lmmunohposomes r cogmze specific 
epltopes on the target cell The concept of lmmuno- 
llposome-medlated drug targeting revolves the combma- 
tmn of hposome preparatmn techmques, Ab couphng 
methods, the detection of specific binding to the target 
and the demonstration of a pharmacologacal effect on 
the target cell The stepwlse ~mprovement of such com- 
plex systems remains the subject of ongoing and future 
mvesugatlons [1,2] 
Most of the concepts of preparaUon of ~mmunohpo- 
somes winch contain cytostaUc drugs remain at the 
level of basic development In view of a therapeutic 
apphcatmn we intend to estabhsh methods which allow 
the preparation of stable, non-toxic undamellar ~m- 
munohposomes on a preparatwe scale Beanng these 
alms m rmnd, we dexqsed m tlus study effectwe anti- 
body couphng methods 
The covalent couphng of Abs, Ab fragments or 
peptldes to hgands winch are located on the surface of 
hposomes can be achieved by numerous chemical meth- 
ods [3-16] 
Bffunctmnal hgands have become useful tools for the 
couphng of proteins to hposomes Among a vanety of 
such molecules, N-succlmmldyl-3-(2-pyndyldlthlo)pro- 
pinnate (SPDP) is currently one of the most used lin- 
kers, although ~t has a number of disadvantages hke its 
suscept~inhty to traces of reducing agents and the short 
half-hfe of the reactwe sulfhydryl groups [16] N-Succx- 
nlrmdyl-S-acetyltinoacetate (SATA) is an alternatwe 
couphng agent [16] 
In tins work we present he results that were ob- 
tained by the direct comparison of Ab couphng meth- 
ods using SPDP and SATA as hnkers to hposomes 
which contmned N4-oleylcytosme arabmoslde (NOAC), 
a hpopinhc denvatwe of arabmosylcytoslne, as cyto- 
static prodrug [17,18] In particular, the couphng of the 
two Abs, B8-24 3 specific for the mouse MHC class I 
H-2k b surface antigen on EL4 mouse T lymphoma cells 
and IB16-6, specific for a surface antigen on B16 mouse 
melanoma cells, to small umlamellar drug carrying hpo- 
somes was lnvest~gated In addmon, the new highly 
fluorescent hpopinhc dye N,N'-b~s(1-hexylheptyl)- 
3,4 9,10-perylenebls(dlcarboxlnude) (BHPD) was used 
as fluorescence label for the hposomes 
Materials and Methods 
Materials 
The hpld soy phosphaladylchollne (SPC, Eplkuron 
200) was obtained from L Meyer, Hamburg, F R G 
Phosphaudylethanolamane (PE) was from Lipid Prod- 
ucts, S Nutley, Surrey, U K Cholesterol, 3-malelrm- 
doproplomc acid, 6-malelmxdocaprolc a id, N-(3- 
malelrmdoproplonyloxy)succmlmade, N-(6-malelmldo- 
caproyloxy)succlmmade, Ellman's reagent (5,5'-dltino- 
bls(2-mtrobenzolc a id), DTNB), dltinothreltol and N- 
ethylmalelmlde were from Fluka, Buchs, Switzerland, 
N(Succmlrmdyl-3-(2-pyndyltino)proplonate (SPDP) and 
Sephadex G-50 medmm were from Pharmacm 
Metrlzamlde was obtained from Sigma, St Louis, MO, 
U S A All analyttcal grade buffer compounds, odmm 
cholate, DL-a-tocopherol, SdlCa gel 60 and the orgamc 
solvents were from Merck, Darmstadt, F R G 
The radxoactlve compounds N-succmlmldyl[2,3- 
3H]proplonate (3H-NSP, 2 8-4 1 TBq/mmol), 1,2-dl- 
palmltoyl-L-3-phosphatldyl[ N-methyl-3H]chohne, (3H- 
PC, 15-3  Bq/mmol) and manganese chloride 
(54MnC12) were from Amersham Int, Amersham, U K 
N2-Palmatoyl-L-lyslne methyl ester HC1 (PL) was 
synthesized as described [15] The hpopinhc malelrmde 
derivatives N 6-(3-malelmldopropmnyl)phosphaudyl - 
ethanolarmde (MP-PE) and N6-(6-malemudocaproyl) - 
phosphaudylethanolarmne (EMC-PE) were prepared m 
analogy to the pubhshed synthesis of N-(4-(p- 
malelrmdophenyl)butyryl)phosphatldylethanolamlne [4] 
N4-Oleyl-ara-C (NOAC) was prepared as described be- 
fore [17] and the hpophlhc metal complexmg agent 
DTPA-stearate as described in Ref 19 
The Inghly fluorescent hpophlhc perylene dye N, N'- 
bls(1-hexylheptyl)-3,4 9,10-perylenebls(dlcarboxlmlde) 
(BHPD) was obtained from 7-trxdecanamlne as de- 
scribed before [20] Before use BHPD was purified on a 
Sdlca-gel column with CHC13 as eluent 
N-Succlnlmldyl-S-acetylthloacetate (SATA) was pre- 
pared according to Ref 21 
Methods 
Synthesis of N6-(6-maletmtdocaproyl-N 2-palmttoyl-L - 
lysme methyl ester (EMP-PL) 
6-Malelmadocaprolc acid (0 96 g, 4 5 mmol) dissolved 
m 4 ml dry CH2C12 were adjusted to pH 7-8 with 
N-methylmorphohne After addition of 1 02 g (4 95 
mmol) DCCI and sUrnng for 10 mln 1 96 g (4 5 mmol) 
N2-palmltoyl-L-lysme methyl ester HCI (PL) were ad- 
ded The reaction rmxture was stirred at room tempera- 
ture for 18 h m the dark The precipitate was filtered off 
and washed with 10 ml CH2C12 and the combined 
filtrates evaporated to dryness The residue was dis- 
solved in 20 ml CH2C12 and chromatographed on a 
slhca-gel column (21 5 × 5 cm) The colunm was first 
eluted with 2 5 htre (CH2C12, followed by 2 5 htre 
CH2C12/MeOH (97 3, v/v), 1 htre CH2C12/MeOH 
(95 5, v/v) and 2 htre CHzClz/MeOH (90 10, v/v) 
The requared product was eluted within the fourth elu- 
tlon step FracUons were pooled and evaporated to 
dryness yielding I 7 g (67%) of analyUcally pure product 
which was homogeneous (R f=07)  by TLC using 
CH2CI2/MeOH (95 5, v/v)  as eluent The functional 
groups of the ultrawolet absorbing compound (254 nm) 
were ldenUfied on TLC by means of spray reagents [15] 
l'he identification of the product was confirmed by 
elementary analysis and mass spectroscopy (m/z  = 592) 
Accordingly, the hpopluhc malelnude derivative N6-(3 -
malelnudoproplonyl)-N2-palnutoyl-L-lysme methyl es- 
ter (MP-PL) was prepared 
Preparatton of N4-oleyl-ara-C hposomes containing vart- 
ous hpophthc rnaletmtde derwatwes 
Small undamellar llposomes were prepared by deter- 
gent dialysis as descnbed before [17] The matrix hpld 
composmon used throughout all hposome preparations 
was soy phosphatldylchohne (SPC)/cholesterol/DL-a- 
tocopherol at 1 0 2 0 01 mol parts with 20 mg SPC/ml 
(26 #mol/ml)  lmtml hpld concentration The malemude 
derlvatwes MP-PL, MP-PE, EMC-PL and EMC-PE 
were added at 0 02 or 0 05 mol parts Nn-oleyl-ara-C 
(NOAC) concentraUon was 0 2 mol parts The hpo- 
phlhc fluorescent label BHPD was Incorporated at 0 006 
mol parts into the hposome membranes 
All hplds Including the corresponding malelnude de- 
nvatwe plus NOAC and BHPD were dissolved in 
MeOH/CHC13 (1 1, v/v)  Sodmm cholate as detergent 
was added at a ratio of 0 6-0 7 moles referred to the 
sum of the concentraUons of all membrane-fornung 
hplds In some preparations the llposomes were labeled 
by addmon of trace amounts of 3H-PC or by the 
mcorporaUon of 0 003 mol parts of the hpopluhc helat- 
ing agent DTPA-SA to which radioactive manganese 
(54Mn2+) ions were complexed after hposome forma- 
tion [19] After the removal of the orgamc solvents on a 
rotatory evaporator (40 o C, 60 rmn) the hpld/detergent 
nuxtures were solub~hzed by addmon of phosphate 
buffer (67 mM dlsodmm hydrogen phosphate dlhy- 
drate/67 mM potassium dlhydrogen phosphate (pH 
7 4)) The resulting nucellar solutions (10-20 ml) were 
dialyzed against 5-10 1 of the same buffer at 40°C for 
the first 2 h, followed by dialysis at 25 °C for another 
24-36 h The hposome preparations were filtered 
through 0 45 #m sterile filters (Sartonus) and stored at 
4 o C Llposome s~zes and homogeneity were deternuned 
by laser light scattering and negattve stare freeze-frac- 
ture electron microscopy [17] 
The mean number of membrane-fornung molecules, 
wluch comprised all hpopluhc compounds constituting 
the membrane bdayer of one hposome and the total 
number of hposomes formed by the hpld concentraUon 
umt of 1 mg SPC/ml, were calculated from the mean 
vesicle diameters obtaaned from the laser hght scattenng 
data and from the assumptions on vesicle geometry 
parameters as made by Huang and Mason [23] For 
example, the membrane of a spherical hposome with a 
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dmmeter of 50 nm contains 20 000 phosphaudylchohne 
molecules, based on the volume of one PC molecule of 
1 253 nm 3 Assuming the same volume for all other 
membrane constituting molecules, approximately 400 
malonude molecules (MP-PL or MP-PE) are dlstnb- 
uted over the bllayer of one hposome 
Determmatton f hposome concentrattons by BHPD fluo- 
rescence 
The fluorescent dye BHPD was used to measure 
hposome concentrations and as a fluorescent marker for 
cytofluorometrlc analysis of hposome-cell binding (cf 
Binding experiments) L~posome concentrations were 
deternuned by the measurement of BHPD absorption at 
526 nm in MeOH/CHCI  3 (1 1, v /v)  or at 522 nm m 
aqueous media (67 mM phosphate buffer (pH 7 4)) with 
a Slumadzu UV 240 instrument BHPD concentrations 
below 4 10 -7 M were measured with a SPF-500 Amlnco 
spectrofluorometer at 489 nm exotaUon and 533 nm 
enusslon wavelength 
The stabd~ty of BHPD incorporation into the hpo- 
some membrane was monitored by dmlysls of 0 5 ml 
llposome ahquots m Spectrapor 2 tubings against 200 
ml 67 mM phosphate buffer (pH 7 4) at 4°C during 30 
days The BHPD concentrations were deternuned m the 
llposomes at intervals of 48 h 
Reactwtty of the hposomal maletmtde functions 
The concentraUons of reactive malelrmde groups 
s~tuated on the outer hposome surface was determined 
by the reacUon with an excess of cystelne followed by 
the deterrmnatlon of unreacted cysteme with Ellman's 
reagent [23] 
To 100/~1 hposomes containing a calculated amount 
of 1 10 -5 mol malelrmde groups that are distributed 
over the tuner and outer layers of the hpld bllayer, 
2 5 10-5 tool cystelne was added m 67 mM phosphate 
buffer (pH 6 0) The mixtures were kept under mtrogen 
and stirred dunng 30 mln Then 3 2 10 -5 mol Ellman's 
reagent (DTNB) m Trls buffer (0 2 M 2-armno-2-hy- 
droxymethylpropane-l,3-dlol/0 2 M HC1 (pH 8 2)) were 
added to a final volume of 1 ml The reaction product 
of excess cystelne with DTNB was measured after 10 
nun at 412 nm and compared to the value obtained with 
reference llposomes containing no malexrmde deriva- 
tives 
A ntlbodws 
The monoclonal Ab B8-24 3 (mouse IgG2b, MHC 
class I, ant1 H-2k b) [24] was obtained from ascates of 
BALB/c mace, as previously described [25] The Ab was 
prec~pltated with 40% ammomum sulfate and further 
punfied by HPLC on a hydroxyapatlte column (100 × 
7 8 mm, BloGel HPHT TM, Blo-Rad) using a phosphate 
buffer gradient (10-300 mM (pH 6 8)) with a flow of 
0 5 ml per rain 
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The rat monoclonal Ab IB16-6, an IgG2a, was pro- 
duced as previously described [26] 
Anttbody labehng wtth N-succtmmMyl[2,3-3H]proptonate 
(ZH-NSP) 
The Abs were trace labeled with 3H-NSP according 
to the method of Kummer [27] Antibody solutions (1 
mg/ml) in 0 1 M sodium borate/0 1 M HC1 ~lus 0 5 M 
sodium chloride (pH 0 5) were reacted with H-NSP at 
a 50% molar excess during 1 h at 0°C  Unreacted 
3H-NSP was removed by dialysis against wo 1000-fold 
volumes of 67 mM phosphate buffer 
Anttbody-hposome couphng wlth SPDP 
Modtftcatzon ofanttbodzes wtth SPDP 
SPDP was hnked to the Abs according to the method 
described by Carlsson [28] with manor modifications 
To 10-40 mg/ml  Ab in 0 1 M phosphate buffer/0 1 
M sodium cb_lorlde (pH 7 5) a solution of SPDP (150 
mM m ethanol) was slowly added at room temperature 
until the molar ratio of Ab to SPDP was either 1 24, 
1 12 or 1 6 The reaction lasted 60 mln, followed by 
dialysis at 4 ° C over 24 h against wo 1000-fold volumes 
of phosphate buffer to remove unreacted SPDP The 
dialyzed Ab-PDP was stored at 4°C The amount of 
linked SPDP molecules was detenmned from ahquots 
after reduction of the chsulfide bonds with a 100 mM 
dltluotreitol solution by measurement of the absorption 
of 2-ttuopyrldone at 343 mn 
Reductton of Ab-PDP and couphng to maletmlde hpo- 
somes 
The Ab-PDP solutions were chalyzed against acetate 
buffer (0 1 M sodium acetate/0 1 M acetic acid plus 0 1 
M NaC1 (pH 4 5)) at 4 ° C over 24 h Dlttuothreitol was 
added to a final concentration of 25 mM After 60 mln 
incubation at 25 °C the reaction mixture was 
fractionated at room temperature on a Sephadex G-50 
column (30 × 1 cm) with 67 mM phosphate buffer (pH 
6 0) With a flow of 0 5-1 ml /nun the activated Ab 
(Ab-P-SH) was separated from dlthlothreitol and 2- 
ttuopyrldone The coupling to malelmade hposomes was 
performed at 25°C immediately after column sep- 
aration of the activated Ab Molar ratios of Ab-P-SH to 
hposomal malelrmde of 1 10, 1 20 and 1 40 were 
used Antibody concentrations varied between 0 15 and 
0 6 mg/ml and the hpid concentration was 1-5 mg 
SPC/ml The coupling was performed under mtrogen 
with moderate sttrrlng during variable time periods (cf 
Results) in volumes of 2-12 ml, depending on the 
corresponding ratios N-Ethylmalemnde dissolved in a 
rnmunal volume of 67 mM phospahte buffer (pH 7 4) 
was added at a 24-fold excess referred to the Ab con- 
centration to stop the reaction 
Anttbody-hposome couphng wzth SA TA 
Modlfzcatton of anttbodtes with SA TA 
The Ab modification with SATA was performed 
following the protocols as described [16,21] The Ab 
dissolved in 50 mM phosphate buffer/1 mM EDTA 
(pH 7 5) at concentrations of 4-10 mg/ml  (0 25-1 10 -9 
M) were reacted uring 60 man at 25 °C under mtrogen 
and gentle stlrnng with SATA (150 mM) whtch was 
dissolved in a mlmmal volume of dlmethylformanude 
The molar ratios of Ab to SATA were 1 24, 1 12 and 
1 6 Unreacted SATA was removed by dialysis at 4°C 
against 1000 volumes of the same buffer over 24 h 
To measure the amounts of Ab-hnked SATA, ahquots 
of Ab-ATA were deacetylated with hydroxylamme, fol- 
lowed by the determination of free sulfhydryl groups 
with Ellman's reagent as described above 
Deacetylatton of Ab-ATA and couphng to maletmzde 
hposomes 
1 ml of the Ab-ATA solution was deacetylated by the 
addition of 0 1 ml hydroxylarmne HCI (0 5 M in 50 
mM phosphate buffer/25 mM EDTA (pH 7 5)) dunng 
60 man at 25 °C under nitrogen and stirnng Couphng 
of activated Ab (Ab-A-SH) to malelmade hposomes was 
carried out immediately thereafter at pH 6 0 and at 
molar ratios of Ab-A-SH to hposomal malelmlde mole- 
cules of 1 10, 1 20 and 1 40 using an Ab-A-SH con- 
centratlon of 0 3 mg/ml  The reaction was stopped at 
various time points (0 2 to 20 h) after incubation at 
25 °C by the addition of N-ethylmalexmlde at a molar 
ratio of 1 24 
Separatton of tmmunohposomes from free anttbody 
Uncoupled SPDP- or SATA-modlfied Abs were sep- 
arated from lmmunohposomes using two different 
methods To follow the coupling reaction between 
activated Ab and malelmlde-hposomes ahquots of 100 
/~1 were withdrawn from the reaction mixture at differ- 
ent time intervals (cf Fig 1) Free Ab was separated 
from immunohposomes by HPLC using a Bio-Gel TSK 
40 (300 × 7 5 mm) column and a flow of 67 mM phos- 
phate buffer (pH 7 4) of 0 75 ml/rmn Liposomal BHPD 
absorption was momtored at 522 nm and fractions of 
free Ab and lmmunohposomes were collected and 
pooled separately The Ab concentrations were de- 
termined by measurement of 3H-NSP activity by scintil- 
lation counting 
The second method was used to separate larger 
volumes (5-10 ml) of the immunohposome mixtures 
Uncoupled, activated Abs were separated from the lm- 
munohposomes by flotation on a discontinuous 
metrlzamlde gradient [3,8,29] In a 5 ml mtrocellulose 
ultracentnfuge tube (Beckman, Ultraclear) the im- 
munohposome couphng solution was mixed with 60% 
metrlzamade to yield a final concentration of 20% 
metrlzanude, overlayed by 2 ml of 10% metrlzanude and 
followed by 0 5 ml 67 mM phosphate buffer (pH 7 4) as 
top layer The density gradient was centrifuged uring 
12-16 h at 95000 ×g at 4°C m a L8-9M ultracentri- 
fuge (Beckman) The floating lmmunohposomes, which 
were visible as a pink fluorescent band, were carefully 
removed from the underlying metrlzamide phases, 
pooled and dialyzed twice agamst 400 ml of 67 mM 
phosphase buffer (pH 7 4) to remove reversibly bound 
metnzamlde 
Kmettcs and efftctency of the bmdmg of SPDP- and 
SA TA-modtfted anttbodtes to maletmtde hposomes 
Binding curves of SPDP- or SATA-modlfled Abs to 
malelmlde hposomes were obtained by removing 
ahquots from the incubation mixtures at various sam° 
phng umepomts and stopping the couphng reaction 
with N-ethylmalellnlde Excess of free activated Ab 
(Ab-P-SH, Ab-A-SH) was separated by HPLC on a 
TSK40 column Fracuons contaamng lmmunohposomes 
were collected and pooled (pool 1) and the hpld con- 
centraUon determined by BHPD fluorescence The con- 
centraUons of coupled Abs in pool 1 and of free 
activated Abs (Ab-P-SH, Ab-A-SH) collected in pool 2 
were determined by scintillation counting of the 3H-NSP 
labeled Abs 
In vttro bmdmg of tmmunohposomes to target cells 
Cell culture 
The T cell lymphoma cell hne EL4 of H-2k b haplo- 
type detectable with the B8-24 3 Ab, the hepatoma cell 
line B16-F10 specifically recogmzed by the IB16-6 Ab 
and the thymoma cell hne BW5147 (H-2 k) as a negative 
control were cultured in Iscove's modified Dulbecco 
medium (IMDM, KC Blologtcal, Lenexa, KS, U S A ) 
supplemented w~th 5% heat reactivated fetal calf serum 
(Glbco, Grand Island, NY, U S A ), 10 mM L-gluta- 
mine (KC Biological), 100 IU/1 pemcdhne/strepto- 
mycm (KC Biological) and 0 1 mM 2-mercaptoethanol 
(Merck, Darmstadt, F R G ) The cells were grown in 
plasUc culture flasks (Falcon, Oxnard, CA, U S A )) at 
37°C, 5% CO 2 in a hurmdlfied incubator Adherent 
cells were detached by brief treatment with trypsin/ 
EDTA (Glbco) 
Bmdmg expertments 
Immunofluorescence and cytofluorometnc analysts 
Binding activity and specificity of natwe and 
acUvated Ab-P-SH and Ab-A-SH were routinely tested 
in vitro Anlabody-cell binding was monitored by lm- 
munofluorescence as previously described [30] using 
goat-anti-mouse FITC-IgG (TAGO, Burhngame, CA, 
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U S A ) for the labehng of B8-24 3 and goat-anti-rat 
FITC-IgG (EY Laboratones, San Mateo, CA, U S A ) 
for IB16-6, respecUvely for second Ab labelmg Specific 
lmmunohposome c ll binding was determined by cyto- 
fluorometrlc analysis based on the fluorescence of 
BHPD incorporated into the hposome membranes of 
the cell bound hposomes (cf hposome preparaUon) 
Target cells (1 5 106) suspended m phosphate buffer 
were mixed with lmmunohposomes (1-130 nM, corre- 
sponding to 2 5 106 hposomes per cell) m a volume of 
300-400/~1 in glas test tubes during 60 nun at 4°C The 
cells were then washed three umes with 1 ml of 67 mM 
phosphate buffer (pH 7 4) contalmng 1% bovine serum 
albunun and 0 02% sodmm azade and resuspended m
0 5-1 ml of the same buffer The cell bound BHPD 
fluorescence intensity was measured on an Epics Profile 
Fluoro Cytometer (Coulter Corp ) at 470 nm excitation 
and 530 nm enuss~on wavelength 
Binding of BHPD-labeled hposomes was determined 
by the measurement of the fluorescence intensity in 
gated detection windows which were set individually for 
chosen populations of viable EL4 and B16 cells, respec- 
tively Non-specific Ab-hposome binding was de- 
termined by incubating B8-24 3-hposomes with B16-F10 
cells and IB16-6-hposomes with EL4 cells, respectively 
(cf Table II) 10000 gated cells were analyzed at flow 
rates of 500-1000 cells/s For Ab-speclfic hposome 
binding the window was set m a manner that natural 
cell fluorescence (Fig 2, peak A) and fluorescence from 
the non-specifically adsorbed, Ab-free hposomes (Fig 
2, peak B) was excluded The fluorescence intensity of 
bound lmmunohposomes measured in the preset window 
(Fig 2, peak C) is gwen m percent of the total fluores- 
cence intensity from all cells analyzed and measured m 
the widest window 
Competmon of tmmunohposome c ll bmdmg by free 
anttbody 
Prior to the addition of lmmunohposomes to the EL4 
target cells free Ab was added as binding competitor 
1 5 10 6 EL4 cells were incubated uring 60 mln at 4°C 
either with B8-24 3 Ab (0 1 nM), corresponding to 
4 108 molecules per target cell, or with an undiluted 
B8-24 3 hybrldoma cell culture supernatant and at 1 2, 
1 20, 1 200, 1 2000 and 1 20 000 dilutions thereof 
Accordingly, B16-F10 cells were incubated with 
equally diluted IB16-6 Ab solutions tarting from 0 025 
nM 
After three washings with 67 mM phosphate buffer 
(pH 74), which contmned 1% bovine serum albumm 
and 0 02% sodium azade, the cells were incubated at 
4°C dunng 1 h m a volume of 0 36 ml with 2 5 106 (26 
nM) lmmunohposomes per target cell An average of 1 3 
Ab was coupled per vesicle and binding to the cells was 
deterlmned by cytofluorometrlc analysis as described 
above 
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Morphology of B8-24 3-hposome bmdmg to EL4 cells 
Ab-hposomes and MP-PL-hposomes were incubated 
w~th EL4 cells for specific binding using the same 
con&tmns as above BW5147 cells were used as nega- 
tive controls After incubation with hposomes the cells 
were washed twice with 0 1 M sodmm cacodylate buffer 
(pH 7 2), fixed with 2% glutaraldehyde for scanning 
electron nucroscopy (SEM) and seeded on glass covers- 
hps precoated with poly-L-lysme (M r 60 000, Sigma, St 
Lores, MO, U S A ) The dehydrated and dried samples 
were coated with gold (10 nm) and exanuned m a SEM 
505 (Phlhps) 
For transnusslon electron microscopy (TEM) the cells 
were incubated uring 60 nun at 4°C, followed by an 
additional mcubaUon at 37°C dunng 120 nun The 
cells were then preftxed with 2% glutaraldehyde plus 
0 8% paraformaldehyde and postflxed with an aqueous 
soluUon of 1% OsO 4 containing 1 5% K4(FeCN) 6 Fixed 
and pelleted cells were transferred into 2% agar, dehy- 
drated in an alcohol series and embedded mto epon 
Ultratlun secUons contrasted with uranyl acetate and 
lead citrate were stu&ed m a TEM 420 (Pluhps) 
Results 
Properttes of NOAC-hposomes contammg vartous 
maletmtde dertvatwes 
NOAC-hposomes containing 0 02 tool parts of the 
malelrmde derivatives MP-PL, MP-PE, EMC-PL and 
EMC-PE were of 50 nm mean vesicle diameter and 
physically stable for more than 60 days when stored at 
4°C  At 0 05 mol parts malelmlde derlvatwe incorpo- 
rated, the hpsoomes were comparably stable with the 
excepUon of the MP-PL hposomes that formed precipi- 
tates soon after preparation With all types of func- 
tlonahzed hposomes a reduction of their binding activ- 
ity during storage was observed We chose to use MP-PL 
as hnlong agent because of xts simple synthesis and 
saUsfactory hposomal mcorporaUon stablhty 
For the calculation of the molar ratios of Ab to 
couphng agent (SATA, SPDP) to reactive malelmlde 
groups on the surface of one hposome, the llposomes 
contmnlng the lmtml concentration of 5 3 10 -4  M 
(0 02 mol parts as referred to SPC) malelmlde derivative 
were diluted to obtain molar ratxos of Ab to malemude 
of 1 10, 1 20 and 1 40 The fluorescent dye BHPD is 
very stably incorporated wttlun the hposome mem- 
branes Due to its hagh fluorescence quantum yield, very 
low BHPD concentrations of 10 -7  to  10 -9  M are 
sufficient to obtain tughly fluorescent hposomes The 
dye does not interfere w~th other membrane compo- 
nents, and because of its high hpophdlclty no measura- 
ble leakage of BHPD from the hposomes occurred (data 
not shown) These properUes render BHPD partxcularly 
statable for the labeling of hposomes and the detectxon 
of their binding to cells by fluorometrlc methods 
Anttbody-hposome couphng 
Anttbody actwatton wlth SPDP and SA TA 
The most important advantage of using SATA over 
SPDP is that no reducing agent hke &ttuothreltol ~s 
reqmred for the actlvaUon of the thlol groups Remain- 
ing traces of the reducing agent &rmmsh the efficiency 
of the couphng reaction [28] The actwatlon of SATA is 
accomphshed with hydroxylamme wluch has the ad- 
dlUonal advantage to increase the stabdlty of free ttuol 
groups [16,21] 
The deacetylat~on reacuon yielding thlolated Ab 
should last 30-60 man to guarantee quantitative de- 
blocking of the thlol-groups 
The SPDP couphng method was more time consum- 
ing with the necessity of two dialysis and one column 
chromatography steps to remove unreacted small mole- 
cules The SATA method afforded only one &alys~s 
step after its couphng to the Ab 
Both Abs (B8-24 3 and IB16-8) which were denva- 
tlzed with SPDP formed precipitates dunng the reduc- 
tion step with &tluothreltol at a pH of 4 5 The amount 
of the precipitate formed was dependent on the molar 
SPDP to Ab raUo At a ratio of 12 SPDP to 1 Ab, 6-7  
(50-60%) SPDP molecules were hnked to one Ab mole- 
cule as determined by the ywld of 2-thlopyndone 
SATA derlvaUzed Ab &d not precipitate during 
actwatlon The exact number of SATA molecules hnked 
per Ab could not be determined by spectroscopic meth- 
ods Therefore, the differing numbers of effectwely hn- 
ked 3H-NSP labeled Ab to the malexmlde funct~onahzed 
llposomes were taken to compare the efficiency of the 
two couphng agents 
In Fig 1, the reaction t~me dependence of the cou- 
phng of either SPDP (filled symbols) or SATA (open 
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Fig 1 Coupling of SPDP- and SATA-mo&fled B8-24 3 Ab to MP-PL 
hposomes at molar raUos of SPDP to Ab of 1 12 (e) and 1 24 (A) 
and o fSATAat  1 6 (o ) ,1  12(<>),and 1 24(zX) w l tha l  40 molar 
ratio of Ab to malemude groups on the hposomes The tmual con- 
centraUon of B8-24 3 was 2 10 -6 M ( = 100%) The couphng reacuon 
was made at room temperature under mtrogen and at pH 6 0 
symbols) modified B8-24.3 Ab to MP-PL hposomes i  
shown. The coupling via SPDP was most efficient at the 
ratio of 24 SPDP to 1 Ab with a rate of 20-25% after 
1-4 h incubation time 
Usmg SATA as couphng agent, tugher activttles were 
obtained at lower SATA Ab ratios At a ratio of 6 1 a 
binding rate of 20% was obtained Maxmaal and repro- 
duclble binding resulted with the 12 1 ratio with rates 
of 60-65% Ab bound at incubation times of 2-4 h 
Generally, incubations lasting longer than 4 h did not 
increase the couphng efficiency 
The SATA modified Ab B8-24 3 had an optmaal 
coupling efficiency at a pH of 6 with 62% bound after 2 
h incubation time Bmdmg efficiency was reduced to 
48% and 34% at pH values of 5 and 4, respectively 
The number of reactwe malelnude groups on the 
hposome surface mfluenced the yield of coupled Ab At 
molar Ab to hposomal malelnude ratios of 1 10 and 
1 20 the binding efficiency of SATA activated B8-24 3 
Ab was reduced by 50% for each ratio as compared to 
the usual ratio of 1 40 (data not shown) At the molar 
ratios of 1 6, 1 12, and 1 24 of SPDP and SATA used 
to modify the Abs no loss of their specific binding 
actlvaty was observed 
Cytofluorometnc determlnatmn of tmmunohposome-cell 
bmdmg 
The specific binding of lmmunohposomes to target 
cells was exanuned usmg MP-PL-lmmunohposomes that 
were coupled with SATA The specific binding activity 
of the Abs was checked at all stages of thetr mochfica- 
txon by lmmunofluorescence The following results um- 
manze the effects of the vanataon of different experi- 
mental parameters Flow cytometrlc analysis was made 
by the use of the hposomal BHPD fluorescence to 
detect lmmunohposome c ll binding The fluorescence 
mtensiUes of the hposomes were measured m preset and 
constant windows as shown m Fig 2 (cf Methods) 
Incubatton condtttons and compentwn experiments 
To deternune optunal tmmunohposome binding to 
the target cells, the incubation conchtlons were modified 
as follows (a) varying the number of hnked Ab per 
hposome (cf Table I), (b) varying the concentration f
lmmunohposomes incubated per target cell and, (c) 
changing the mcubatmn volume At least 0.3-2 Abs 
must be linked per hposome m order to obtain specific 
bmdmg to the target cell With 0 3 Ab per hposome we 
found a bmdmg rate of 26% (of Table I) wluch indi- 
cates that about two thirds of the hposomes chd not 
contain a linked antibody 
The cross-control incubations of Ab-hposomes with 
nonspecffic target cells demonstrate he specificity of 
the Ab-hposomes (cf Table II) In contrast to the 
results of other mvestigat,ons, we found that the hnkage 
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Fig 2 Cytofluorometnc determination f hposome-cell bmdmg Flu- 
orescence intensities ofBHPD contalmng hposomes bound to B16-F10 
cells (A) self fluorescence of B16-F10 cells, (B) non-speoflc bmdmg 
of MP-PL hposomes (controls) and (C) specific binding of IB16-6 
modified hpsoomes Bar, preset measuring window for the deternuna- 
tlon of specific Ab-hposome binding Slrmlar window settmgs were 
used for the measurement of B8-24 3 mochfied hposomes to EL4 cells 
of more than two Ab molecules per hposome does not 
slgmficantly increase binding eff, oenoes [3-5,10,16] 
In Table II the bmchng of lmmunohposomes, de- 
pending on the hposome concentraUon is shown Slg- 
mflcant Ab mechated binding of hposomes was actueved 
at concentrations of lmmunohposomes m the range of 
20-130 nM Control hposomes lacking hnked Ab 
showed binding rates of only 0 1-4 2% compared to 
43-78% of the hposomal BHPD fluorescence detected 
on the cells that were incubated with variable con- 
centrations of lmmunohposomes (cf also Fig 4) 
The incubation volume m winch the lmmunohpo- 
somes were rmxed with the target cells strongly in- 
fluenced the binding rates Adherent B16-F10 cells (1 5 
106) were incubated uring 60 nun at 4°C with 26 nM 
TABLE I 
L4posome-cell binding m dependence of numbers of S.4TA-coupled Ab 
molecules per hposome 
Immunohposomes (26 pM or 4 1012 vesicles) or MP-PL hposomes 
were mcubated with 1 5 106 cells dunng 60 nun at 4°C m a volume 
of 0 36 ml Percentage of cell bound BHPD fluorescence was de- 
termined by cytofluorometry 
Anubodtes Percent cell bound BHPD fluorescence 
coupled per mununo- MP-PL cells 
hposome hposomes hposomes alone 
ELA cells 
03 26 1 5 0 
1 3 87 2 0 
B16-F10 cells 
03 13 03 0 
1 2 66 03 0 
1 9 78 03 0 
--- 8 Ioo 
ao ~ 
60- a 
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D, lut,on of compet,ng ant,body (-log ~ 
Fig 3 LJposome binding competmon with free B8-24 3 and IB16-6 
Ab added before incubation of the EL4 and B16F10 target cells with 
hposomes @, B8-24 3 coupled hposomes, II, IB16-6 coupled hpo- 
somes, ©, MP-PL hposomes (non-speofic binding to EL4 cells), t2, 
MP-PL llposomes (non-specific binding to B16-F10 cells) The mmal 
concentration of free B8-24 3 Ab was 0 1 nM and that of IB16-6 0 025 
nM Free Ab was incubated uring 60 man at 4°C  with the ceils 
After three washings with 67 mM phosphate buffer (pH 7 4) contain- 
ing 1% boxane serum albumin and 0 02% sodium azade hposomes (26 
nM, 2 5 106 vesicles per cell) were added to gwe a final mcubauon 
volume of 360 /tl Cell bound BHPD fluorescence was determaned 
after mcubatton for 60 man at 4 ° C 
76 
IB16-6 modified hposomes (13 Ab/hposome) m 
volumes of 36 ml, 12 ml and 036 ml Specific lm- 
munohposome binding was haghest with 57% m the 
smallest volume, whereas at 1 2 ml and 3 6 ml only 3 3% 
and 0 5% lmmunohposomes, respectively, were speofl- 
cally bound The competitive action of unmodified Ab 
added to target cells ahead of lmmunohposomes is 
shown for B8-243 and IB16-6 m Fig 3 At excess 
concentrations of (1-4) 108 free Abs per cell corre- 
sponding to (0 6-2 4) 10 -8 M per 1 5 106 tumor cells 
the subsequent binding of lmmunohposomes was re- 
duced to 30% in the case of B8-24 3 (Fig 3, filled circles) 
and to 47% for IB16-6 (Fig 3, filled squares) The 
dilution of the competmg free Ab increased lmmuno- 
hposome binding 
The 20-30% of non-speofically bound control MP- 
PL hposomes to the B16-F10 cells was probably caused 
by weak non-specific binding to absorbed Ab molecules 
on the cell surface The specific binding of lmmuno- 
hposomes to EL4 cells was vasuahzed by scanmng elec- 
tron microscopy (SEM) and transmission electron nu- 
croscopy (TEM), as shown in Fig 4, a-c and Fig 5, 
a-c  
A total number of 4 1012 hposomes (26 nM) func- 
ttonahzed with an average of 1 3 B8-24 3 Abs per vesicle 
a 
Fig 4 (a) SEM appearance of an ELA cell, 12000× Bar 1 6 #m (b) Detatl of the cell surface of an ELA cell wluch was incubated with Ab-free 
control hposomes The arrows show adsorbed single hposomes and hposome aggregates 64000x Bar 0 3 /~m (c) Specific binding of 
B8-24 3-hposomes with single hposomes predonunantly bound to the cell's nucrovllh (arrows), 64000 × Bar 0 3 #m 
TABLE II 
Ltposome-cell bmdtng m dependence of tmmunohposome concentratton 
SATA coupled lmmunohposomes contalmng an average of 1 3 Ab per 
hposome or MP-PL hposomes were incubated as described m Table I
Percentage of cell bound BHPD fluorescence was determined by 
cytofluorometry Non-specific Ab-llposome binding was determined 
by cross-incubations (2 5 106 hposomes/cell) with EL4 and B16-F10 
cells, respectively 
Llposome Percent cell bound BHPD fluorescence 
concentration Ab- MP-PL cells 
(nM) hposomes llposomes alone 
EL4 cells 
1 03  0 0 
5 17 02 0 
26 84 1 0 0 
B16-F10 cells 
4 04 01 0 
22 43 1 3 0 
26 66 2 5 0 
130 79 4 2 0 
Controls 
B8-24 3 on B16-F10 1 2 0 
IB16-6 on EIM 0 2 - 0 
were incubated with 1 5 10 6 EL4 cells, as described in 
Methods Fig 4a shows an EL4 cells with typical surface 
structures Unspecific b inding of MP-PL hposomes is 
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shown in Fig 4b as smgle liposomes or hposome clus- 
ters adsorbed on the cell surface (arrows) Ant ibody 
me&ated specific b inding of hposomes to the cell surface 
ts demonstrated m Fig 4c High numbers of single 
hposomes are bound predominant ly  to the rmcrovdh 
and also to a lesser extent to the smooth surface 
On the cell surface sector shown m Fig 4c which has 
a calculated surface area of about 1 10 -12 m 2 an 
average of 100 hposomes were speofically bound Based 
on a total surface of one EL4 cell of 1 10 -1° m 2, about 
10000 lmmunohposomes would be speofical ly bound 
to the cell The number  of non-speof ical ly bound lipo- 
somes (Fig 4b) was not determined but the visual 
comparison shows that a smaller amount  of the hpo- 
somes were non-specifically adsorbed 
The receptor mediated endocytic uptake of lmmuno-  
hposomes is demonstrated m Fig 5, which, m Fig 5a 
shows an EL4 cell at low magnif ication with several 
attached hposomes (arrows) The Figs 5b and 5c dis- 
play the uptake process of a smgle hposome at different 
stages, showing the electron dense hposomes as black 
dots The sizes of the OsO4-stamed hposomes corre- 
spond to their original diameters On control rmcro- 
graphs these electron-dense particles were not present 
(not shown) The binding to the cell membrane (Fig 5b) 
is followed by the formation of a coated ptt (Fig 5c) 
L__ ! 
Fig 5 (a) TEM morphology ofan EL4 cell which was incubated with B8-24 3-hposomes Bound hposomes can be recogmzed on the cell membrane 
(arrows) 7600x Bar 25 pm (b) Detml of an EIA cell showing a single hposome bound to the cell membrane 230000x Bar 009 ~am (c) 
Formation of a coated p~t mdmatmg the receptor mediated uptake of a single hposome 100 800 × Bar 0 2 ~ m 
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and further lnternahzatlon via coated vesicles (not 
shown) 
Similar n~crographs were obtained with the specific 
binding of IB16-6 modified hposomes to B16-F10 cells 
Discussion 
With the aim of preparing Ab modified hposomes 
that carried N4-oleyl-ara-C as cytostatic drug, and that 
bind specifically to target umor cells, we compared m 
this study the couphng properties of two monoclonal 
IgG Abs to the surface of such hposomes usmg the two 
blfunctlonal coupling molecules SPDP and SATA The 
hposomes were functlonahzed with various hpophihc 
malelmade derivatives and labelled with a highly fluo- 
rescent hpophihc fluorescent dye In spite of the very 
complex membrane compositmn we obtained unllamel- 
lar hposomes of a mean diameter of 50 nm of which the 
Ab couphng capablhty was preserved for more than 14 
days Among the hpophrhc maleinude derivatives MP- 
PL was the most effective in terms of preservation of 
the coupling activity in dependence of hposome storage 
This IS a favourable result because the synthesis of this 
malemude derivative IS simpler, cheaper and less equiv- 
ocal than the PE derivatives Moreover. it can be ex- 
pected that the lysme derivative does not take part m 
lipid exchange as much as the corresponding PE deriva- 
tives 
As described for a comparable system of Ab cou- 
phng to hposomes [16], SATA showed to be a more 
efficient hnker than SPDP, especially concermng the 
following aspects compared to SPDP the hnkmg of 
SATA to amino gorups of Abs followed by the couphng 
of the activated Abs to hposomes i methodically sim- 
pler, safer and faster Due to these advantages, signifi- 
cantly higher yields of coupled Ab molecules are ob- 
tained 
The coupling yield of 60-65% shows that the two-step 
strategy of thioether linkage described here is more 
econormc ompared to the three step method proposed 
recently [15] In the three step procedure hposomes 
contaimng free amino groups, e g wath PE or PL are 
prepared and m a second step maleirmde denvatwes are 
hnked to the hposomes vm armde bonds The disad- 
vantage of lower Ab couphng yields (15-20%) is op- 
posed by the advantage of the high stabihty of the 
amino group containing hposomes wtuch are functional- 
lZed with maletrmde derivatives tmmedxately before the 
couphng of the Ab Moreover, the modiflcatmn of the 
hposomes with malenmde groups is restncted to the 
outer surface of the hposome membrane 
Using the optimized Ab-hposome coupling condi- 
tions, m xatro lmmunohposome-target cell binding ex- 
periments were performed to investigate the feasibihty 
of an In VlVO approach with the aim to target drug 
carrying hposomes to a specific site of the orgamsm 
Irrespective of the blfunctlonal linker used or the 
particular chemclal method apphed to couple Abs to 
hposomes our findings allow to draw the following 
conclusions 
(a) An average of one to two Ab molecules hnked to 
the surface of one hposome is sufficient for specific 
binding of the immunohposome to the target cell Higher 
numbers of Ab molecules hnked to one llposome do not 
increase the binding efficiency and might rather cause 
hposome aggregation and destabihzatlon [6,7] 
(b) To obtain specific binding to the target cells, 
lmmunohposome concentrations i  the range of 20-130 
nM were necessary The complete saturation of the Ab 
binding epltopes may not be necessary for the kllhng of 
the target cell by action of the hposomally incorporated 
cytotoxac drug As suggested by other investigators 
[31,32], receptor mediated endocytlc uptake of a hpo- 
some is increasing the toxac effect of the drug dehvered 
into the cell 
(c) Controversial results have been reported on the 
competitive action of free Abs that occupy bmdmg 
epltopes on the target cells We found a competitive 
effect of free specific Abs incubated with the target cells 
before the addition of the immunohposomes (cf Fig 3), 
using a 10-100-fold excess of competing free Abs Simi- 
lar results were described by Wolff and Gregonadls 
[33], whereas in other studies hke the ones by Heath 
and co-workers [34,35], soluble Ab colncubated with 
Ab-hposomes did not decrease the binding efficacy of 
the hposomes 
(d) The new hpophihc fluorescent dye BHPD is an 
excellent agent for the in vitro monltonng of 
llposome-cell interactions In contrast o the widely 
used hydrophrhc dye carboxyfluoresceln BHPD remains 
Incorporated in a very stable fashion within the hpo- 
some membrane and as compared to more water soluble 
dyes, no leakage occurs in the course of the coupling 
procedures and during llposome storage [6]. A further 
advantage of BHPD is that its fluorescence is not 
quenched after the incorporation i to hposome mem- 
branes and due to ItS very high quantum yield, con- 
centratmns m the range of nanomoles are sufficient o 
detect hposome-cell binding BHPD contains two 
hexylheptyl chains which are located symmetncaUy at
both sides of the perylene ring structure Due to these 
alkyl-chalns it is conceivable that the dye is firmly 
intercalated between the fatty acid chains of both bl- 
layer moieties, preventing its transfer into other mem- 
branes 
Besides that, the incorporation of BHPD into the 
hposomal membrane is not reducing non-specific nter- 
actmns of the hposomes This is remarkable because 
after the incorporation of other hpoptuhc fluorescent 
dyes strong nonspeclfiC interactmns between the hpo- 
somes and cells or bmpolymers occurred We made such 
observatmns for example wath hpophihc derivatives of 
fluorescemanune, dansylcadaverlne, sahcyhc acid and 
4-chloro-7-mtrobenzofurazane which were synthesized 
by us (data not shown) 
Our results support the findings that lmmunohpo- 
some targeting potentially may be more effectwe than 
non-specfflcaUy adsorbed hposomes as drug dehvery 
systems However, opUmal in vavo targeting of drugs by 
means of lmmunohposomes can only be achieved by 
further refinement of these complex systems 
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